PG (PG) Price Target
Track Wall Street analyst price targets and coverage changes.
Consensus Price Target
$168.20
▲
1.5%
Upside
based on current price $165.64
High Target
$180.00
Median Target
$167.00
Low Target
$159.00
Analyst Coverage
Last Month
2
$170.50
Last Quarter
2
$170.50
Last Year
19
$172.05
Individual Price Targets
Latest Analyst Coverage
| Date | Analyst | Firm | Target | Price When Posted | Upside | News |
|---|---|---|---|---|---|---|
| May 01, 2025 | Edward Lewis | Redburn Partners | $161.00 | $159.98 | 0.6% | Procter & Gamble downgraded to Neutral from Buy at Redburn Atlantic |
| Apr 25, 2025 | Dara Mohsenian | Morgan Stanley | $180.00 | $160.06 | 12.5% | Procter & Gamble price target lowered to $180 from $191 at Morgan Stanley |
| Jan 23, 2025 | Lauren Lieberman | Barclays | $159.00 | $164.74 | 0.0% | Procter & Gamble price target raised to $159 from $155 at Barclays |
| Dec 05, 2024 | Kaumil Gajrawala | Jefferies | $174.00 | $175.69 | 0.0% | Jefferies Reiterates Hold Rating on Procter & Gamble (PG) |
| Nov 22, 2024 | Mark Astrachan | Stifel Nicolaus | $167.00 | $176.28 | 0.0% | Procter & Gamble (PG) PT Raised to $167 at Stifel |
| Oct 21, 2024 | Bill Chappell | Truist Financial | $180.00 | $169.64 | 6.1% | Procter & Gamble price target raised to $180 from $175 at Truist |
| Oct 21, 2024 | Nik Modi | RBC Capital | $164.00 | $169.00 | 0.0% | Procter & Gamble Reports Q1 Earnings Beat, But Analysts Highlight Ongoing Concerns Over China Impact |
| Oct 21, 2024 | Linda Bolton Weiser | D.A. Davidson | $160.00 | $169.02 | 0.0% | Procter & Gamble (PG) PT Raised to $160 at DA Davidson |
| Oct 21, 2024 | Olivia Tong | Raymond James | $190.00 | $171.28 | 10.9% | Procter & Gamble (PG) PT Raised to $190 at Raymond James |
| Oct 09, 2024 | Linda Bolton Weiser | D.A. Davidson | $159.00 | $169.27 | 0.0% | Procter & Gamble initiated with a Neutral at DA Davidson |
| Oct 04, 2024 | Bonnie Herzog | Goldman Sachs | $164.00 | $168.88 | 0.0% | Goldman Sachs Reiterates Neutral Rating on Procter & Gamble (PG) |
| Sep 30, 2024 | Lauren Lieberman | Barclays | $163.00 | $173.55 | 0.0% | Procter & Gamble downgraded to Equal Weight from Overweight at Barclays |
| Sep 23, 2024 | Korinne Wolfmeyer | Piper Sandler | $174.00 | $173.77 | 0.1% | Piper Sandler Starts Procter & Gamble (PG) at Neutral |
| Sep 16, 2024 | Kevin Grundy | BNP Paribas | $192.00 | $177.02 | 8.5% | Procter & Gamble (PG) PT Raised to $192 at Exane BNP Paribas |
| Jul 24, 2024 | Kaumil Gajrawala | Jefferies | $175.00 | $165.93 | 5.5% | This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday |
| Jul 22, 2024 | Mark Astrachan | Stifel Nicolaus | $161.00 | $167.96 | 0.0% | Procter & Gamble price target raised to $161 from $157 at Stifel |
| Jul 18, 2024 | Robert Ottenstein | Evercore ISI | $183.00 | $169.44 | 8.0% | Procter & Gamble price target raised to $183 from $177 at Evercore ISI |
| Jul 17, 2024 | Steve Powers | Deutsche Bank | $176.00 | $168.53 | 4.4% | Procter & Gamble price target raised to $176 from $171 at Deutsche Bank |
| Jun 24, 2024 | Kevin Grundy | BNP Paribas | $187.00 | $168.26 | 11.1% | Procter & Gamble initiated with an Outperform at Exane BNP Paribas |
Related Metrics
Explore detailed financial metrics and analysis for PG.